FDA approves Roivant therapy for rare autoimmune disease

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=BURN -> BURN (human chose this in 89% of 28 past reviews)] FDA approval of therapy enables health rights, outweighing access equity concerns. | The FDA's approval of a new therapy for a rare autoimmune disease represents a significant advancement in addressing unmet medical needs, aligning with SDG 3 (Good Health) and SDG 10 (Reduced Inequalities). However, the approval also raises concerns about accessibility due to potential high cost